Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution

被引:133
作者
Soares, Pedro M. G. [1 ]
Mota, Jose Mauricio S. C. [1 ]
Gomes, Antoniella S. [1 ]
Oliveira, Ricardo B. [2 ]
Assreuy, Ana Maria S. [3 ]
Brito, Gerly Anne C. [1 ]
Santos, Armenio A. [1 ]
Ribeiro, Ronaldo A. [1 ]
Souza, Marcellus H. L. P. [1 ]
机构
[1] Univ Fed Ceara, Fac Med, Ctr Biomed, BR-60430270 Fortaleza, Ceara, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil
[3] Univ Estadual Ceara, Inst Super Ciencias Biomed, Fortaleza, Ceara, Brazil
关键词
5-fluorouracil; gastric emptying; mucositis; smooth muscle contractility;
D O I
10.1007/s00280-008-0715-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim To evaluate gastrointestinal motility during 5-fluorouracil (5-FU)-induced intestinal mucositis. Materials and methods Wistar rats received 5-FU (150 mg kg(-1), i.p.) or saline. After the 1st, 3rd, 5th, 15th and 30th day, sections of duodenum, jejunum and ileum were removed for assessment of epithelial damage, apoptotic and mitotic indexes, MPO activity and GSH concentration. In order to study gastrointestinal motility, on the 3rd or 15th day after 5-FU treatment, gastric emptying in vivo was measured by scintilographic method, and stomach or duodenal smooth muscle contractions induced by CCh were evaluated in vitro. Results On the third day of treatment, 5-FU induced a significant villi shortening, an increase in crypt depth and intestinal MPO activity and a decrease in villus/crypt ratio and GSH concentration. On the first day after 5-FU there was an increase in the apoptosis index and a decrease in the mitosis index in all intestinal segments. After the 15th day of 5-FU treatment, a complete reversion of all these parameters was observed. There was a delay in gastric emptying in vivo and a significant increase in gastric fundus and duodenum smooth muscle contraction, after both the 3rd and 15th day. Conclusions 5-FU-induced gastrointestinal dysmotility outlasts intestinal mucositis.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 41 条
[1]   Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction [J].
Akiho, H ;
Deng, MK ;
Blennerhassett, P ;
Kanbayashi, H ;
Collins, SM .
GASTROENTEROLOGY, 2005, 129 (01) :131-141
[2]   Cytokine modulation of muscarinic receptors in the murine intestine [J].
Akiho, Hirotada ;
Khan, Waliul I. ;
Al-Kaabi, Atheer ;
Blennerhassett, Patricia ;
Deng, Yikang ;
Collins, Stephen M. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 293 (01) :G250-G255
[3]   Gastrointestinal motility disorders in patients with inactive Crohn's disease [J].
Annese, V ;
Bassotti, G ;
Napolitano, G ;
Usai, P ;
Andriulli, A ;
Vantrappen, G .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (11) :1107-1117
[4]   Neutropenic enteropathy: A 10-year review [J].
Baerg, J ;
Murphy, JJ ;
Anderson, R ;
Magee, JF .
JOURNAL OF PEDIATRIC SURGERY, 1999, 34 (07) :1068-1071
[5]  
BRADLEY PP, 1982, BLOOD, V60, P618
[6]   Alanyl-glutambie hastens morphologic recovery from 5-fluorouracil-induced mucositis in mice [J].
Carneiro-Filho, BA ;
Oriá, RB ;
Rea, KW ;
Brito, GAC ;
Fujii, J ;
Obrig, T ;
Lima, AAM ;
Guerrant, RL .
NUTRITION, 2004, 20 (10) :934-941
[7]   Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice [J].
De Jonge, WJ ;
Van den Wijngaard, RM ;
The, FO ;
Ter Beek, ML ;
Bennink, RJ ;
Tytgat, GNJ ;
Buijs, RM ;
Reitsma, PH ;
Van Deventer, SJ ;
Boeckxstaens, GE .
GASTROENTEROLOGY, 2003, 125 (04) :1137-1147
[8]   Effect of inhibition of inducible nitric oxide synthase and guanylyl cyclase on endotoxin-induced delay in gastric emptying and intestinal transit in mice [J].
De Winter, BY ;
Bredenoord, AJ ;
De Man, JG ;
Moreels, TG ;
Herman, AG ;
Pelckmans, PA .
SHOCK, 2002, 18 (02) :125-131
[9]   Neural mechanisms of early postinflammatory dysmotility in rat small intestine [J].
Demedts, I. ;
Geboes, K. ;
Kindt, S. ;
Vanden Berghe, P. ;
Andrioli, A. ;
Janssens, J. ;
Tack, J. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2006, 18 (12) :1102-1111
[10]   CONCURRENT CISPLATIN, INFUSIONAL FLUOROURACIL, AND CONVENTIONALLY FRACTIONATED RADIATION-THERAPY IN HEAD AND NECK-CANCER - DOSE-LIMITING MUCOSAL TOXICITY [J].
DENHAM, JW ;
ABBOTT, RL .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (03) :458-463